Calgary, Alberta – January 7, 2025 – Marvel Biosciences Corp. (TSXV: MRVL OTCQB: MBCOF) (“Marvel” or the “Company”) is pleased to announce that it intends to complete a non-brokered private placement of common shares of the Company (each a “Common Share”) at a price of $0.15 per Common Share for gross proceeds of a minimum of $1,935,000 and up to a maximum of $2,500,000 (the “Offering”).
